CXCR3 and neoplasm: Conversely, some studies suggest that concomitant active TB in SCC may paradoxically improve survival through enhanced T-cell mediated anti-tumor immunity, with increased CD3+ T cells, CXCR3+ cells and decreased regulatory T cells in the tumor microenvironment (Kuo et al., 2012).